Cyclo Therapeutics -CW25CYTHWPreferred / convertible
13F holders, Q2 2024 (June 30)1holders −1
0new positions
1sold out
1famous investor
$0.23avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Cyclo Therapeutics -CW25 (CYTHW) in their 13F filings, down 1 from Q1 2024. 0 opened new positions and 1 sold out. The largest holder was Citadel Advisors ($2K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Cyclo Therapeutics -CW25
- CUSIP
- 23254X110
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $19 |
All 13F filers, Q1 2024 → Q2 2024: 281 shares sold, net −281 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Citadel Advisors | — | Reduce -1.8% | 10,793 | $2K |
"% of holder's portfolio" is CYTHW's weight in each manager's 13F, not the share of Cyclo Therapeutics -CW25 the manager owns.